Cannvas MedTech (CSE:MTEC) CEO, Shawn Moniz, was recently interviewed on an episode of Midas Letter Live during which he discussed the company’s business plan and shareholder position. Cannvas MeTech recently went public on the Canadian Securities Exchange this past week and are at the forefront of providing healthcare education in the cannabis space.

During the interview, Moniz provided a detailed description of the company’s services. To him, Cannvas MedTech is a business technology company filling the education gap within the cannabis space. “What we did is, we looked at what is happening in the space and where can you actually create a solution that doesn’t overlap a lot of the players that are in the segment,” he said. “And what we found is, there’s a lot of growers, and there’s a lot of users; but in between, there is something that was missing.”


Cannvas MedTech is designing its proprietary platform, Cannvas.me, a “consumer-centric health sciences platform” that will focus on education for cannabis use.

The company’s philosophy is that they win as long as the consumers learn something. Whether its learning about the differences between hemp oil versus cannabis, THC, CBD or something else. The company’s slogan is “Health Care Through Cannabis” and Moniz and his team have strategically positioned themselves to become an industry leader. The company makes money through user engagement on the site and they have currently partnered with Health Canada and several other research facilities and universities for their content. However, what sets the company apart is that they are putting a lot of time and effort into making sure they understand “what people want, what they don’t want, what they like, what they don’t like, and it’s very contextualized, meaning, if someone is in Vancouver, Toronto, Sydney, Germany, or South America, the site changes.”

Among several other features that Cannvas.me is expected to showcase is that the site has been designed keeping 7 different audiences in mind- ” whether you’re a nurse practitioner, an HCP, a caregiver, a patient, a adult use, even insurance companies – anybody that would want to be part of the space, has a place on Cannvas.me.” Provided it’s legal, the website will also show the consumer support groups and clinics that are in their area. The company is committed to collecting and analyzing data points that will not only serve the back end user but will allow them to have an extremely meaningful contextualized conversation on the Cannvas.me platform. Taking a highly data-centric approach with CRM, the content on the site is curated not just algorithmically but also by a live person. By creating a Health Innovation board that has a couple physicians signed on with the company to curate content, the company makes sure that the content on their site is unbiased and a trustworthy source.

To read the full interview, click here.

 

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE:ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws

Keep reading... Show less

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced Jason Ackerman Chief Executive Officer and Executive Chairman of TerrAscend, Keith Stauffer Chief Financial Officer, and Jason Wild Chairman, will participate in three upcoming conferences:

  • Cowen’s 3rd Annual Boston Cannabis Conference, a virtual event taking place November 30-December 2 , 2020. Jason Ackerman will participate in a panel, U.S. MSOs: The West, on November 30, 2020 at 10:25 a.m. ET . Management will also host one-on-one meetings with investors throughout the conference.
  • 2020 Cantor Fitzgerald Virtual Cannabis MSO Summit, a virtual event taking place on December 15-16, 2020 . Jason Ackerman is scheduled to participate in a fireside chat on December 16 th at 1:00 p.m. ET . To register for the fireside chat: Click Here
  • 23 rd Annual Needham Virtual Growth Conference, a virtual event taking place January 11-15, 2021 . Jason Ackerman is scheduled to participate in a fireside chat on January 14, 2021 at 2:45 p.m. ET . Management will also host one-on-one meetings with investors throughout the conference. To register for the fireside chat: Click Here

The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Keep reading... Show less
  • Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada
  • Agreement with Israeli leader Cantek provides access to Israel’s drugstore channel
  • Finished product is co-branded under Aurora and Cantek brands

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today it has entered into a strategic Supply Agreement (the “Agreement”) with Cantek Holdings (“Cantek”), one of Israel’s leaders in the medical cannabis field.

Keep reading... Show less